Trexquant Investment LP Sarepta Therapeutics, Inc. Transaction History
Trexquant Investment LP
- $8.01 Billion
- Q1 2025
A detailed history of Trexquant Investment LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 187,984 shares of SRPT stock, worth $7.31 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
187,984Holding current value
$7.31 Million% of portfolio
0.15%Shares
24 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$401 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$352 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$351 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$158 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$131 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...